ShangPharma (SHP) Inactive 20-F2010 FY Annual report (foreign)

Filed: 29 Apr 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SHP similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 15.2

[Letterhead of Fangda Partners]

April 29, 2011

ShangPharma Corporation

No. 5 Building, 998 Halei Road

Zhangjiang Hi-Tech Park, Pudong New Area

Shanghai, 201203

People’s Republic of China

Dear Sirs,

We consent to the reference to our firm under the headings “Risk Factors” and “Regulation” in ShangPharma Corporation’s Annual Report on Form 20-F for the year ended December 31, 2010, which will be filed with the Securities and Exchange Commission (the “SEC”). We also consent to the filing with the SEC of this consent letter as an exhibit to the Annual Report on Form 20-F for the year ended December 31, 2010.

Yours faithfully,

/s/ Fangda Partners

Fangda Partners

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.